Blog
New Commercial Partnership and Further Scientific Validation for NeuroVocalix
Cambridge Cognition is pleased to announce the second commercial partnership with a leading pharmaceutical company, for its NeuroVocalixTM platform. NeuroVocalixTM is a unique voice biomarker technology and the product was launched last year and recently presented ground-breaking demonstrable evidence of the potential at a major global Alzheimer’s conference.
NeuroVocalix platform ready for clinical trials
NeuroVocalix enables novel voice-based cognitive assessments to be delivered directly to patients through mobile and tele-health platforms, helping to improve outcomes in clinical trials, aid clinical decision-making and play an important role in the management of long-term conditions such as chronic pain.
web-based testing,
wearables,
voice recognition,
voice,
virtual clinical trials,
technology,
swm,
subjective measures,
social cognition,
smartphones,
schizophrenia research,
schizophrenia,
safety,
research funding,
research,
remote testing,
rare disease,
psychosis,
prodromal,
pro-cognitive,
press release,
presenteeism,
precision psychiatry,
pre-clinical,
poster,
personalised medicine,
patient-centric,
patient recruitment,
parkinson's disease,
pal,
paired associates learning,
occupational health,
objective measures,
normative data,
neuroscience,
near-patient testing,
multiple sclerosis,
ms,
modelling,
mental wellbeing,
mental health at work,
mental health,
mdd,
mci,
major depression,
machine learning,
longitudinal,
ied,
hot cognition,
high-frequency testing,
healthcare,
grant,
funding,
fatigue,
ert,
epidemiology,
emotion recognition,
ecoa,
ebt,
early career researchers,
early alzheimer's disease,
drug development,
digital tools,
digital health,
depression,
dementia,
cognitive wellbeing,
cognitive testing,
cognitive science,
cognitive safety,
cognitive research,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive deficits,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
clinical trial,
cias,
chronic illness,
chronic health conditions,
cantab testimonial,
cantab research grant,
cantab for clinical trials,
cantab,
brain health,
biomarkers,
automatic speech recognition,
autism,
attention,
asr,
alzheimer's disease,
affective cognition,
adolescents,
absenteeism,
aaic2020,
